Overall verdict
Neutral
5.1/10
1-year performance
+37.17%
Score breakdown
Up 37.2% over 1 year, 100% of the 52-week range.
Strongest: Profitability 9.2/10. Weakest: Valuation 2.2/10.
24 analysts, target +0.0% vs the price.
The Coca-Cola Company, a beverage company, manufactures and sells various nonalcoholic beverages in the United States and internationally. The company provides Trademark Coca-Cola, sparkling soft drinks and flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and emerging beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers comprising restaurants and convenience stores.
The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, caffeine free Diet Coke, Cherry Coke, Fanta, Sprite, Simply, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Crystal, Dasani, Fuze Tea, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, I LOHAS, Powerade, Topo Chico, Core Power, Del Valle, fairlife, innocent, Maaza, Minute Maid, Minute Maid Pulpy, Santa Clara, and dogadan brands.
It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The Coca-Cola Company was founded in 1886 and is headquartered in Atlanta, Georgia.
Sector
Consumer Staples
Industry
Beverages
Primary listing
Nyse
United States
CEO
Henrique Braun
Founded
1886
Employees
65 900
Revenue / employee
734 325 USD
Next earnings
February 9, 2027 (estimated)
Institutional holders
- GEODE CAPITAL MANAGEMENT, LLC2.59%
- FMR LLC2.39%
- Bank of New York Mellon Corp0.82%
- Rest of the register94.19%
3 13F filings as of September 30, 2026: US managers above $100M, filed up to 45 days after quarter end. No insiders, no retail. A share on loan is declared by its lender and by whoever bought it from the short seller, so the total can exceed 100%.
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
98.06 USD
52-week low
67.27 USD
1-year performance
37.17%
Rising
Year-to-date performance
40.39%
Rising
Drawdown
0.00%
Near its high
Position in the 52-week range
100% of range
Against the world ETF
Over 26 years, from December 2000 to October 2026, the share did not clearly beat the world ETF once risk is accounted for. It earned less, but once risk is counted it did about as well as the ETF.
$10,000 placed at the end of December 2000 are worth today
| The Coca-Cola | $63,864 |
| World ETF | $65,117 |
| S&P 500 | $91,204 |
| Risk-free placement | $15,894 |
The risk
- Shaking:the share moves about as much as the world ETF.
- Worst fall:-37Â % between February 2020 and March 2020. $10,000 placed at the top fell to $6,301. The world ETF, at worst: -53Â %. Back to its high in 16 months.
The Coca-Cola kept pace with the world ETF since 2000
Value of $10,000 placed at the end of December 2000, dividends reinvested, in dollars
- The Coca-Cola: $63,864
- World ETF: $65,117
- S&P 500: $91,204
- Risk-free placement: $15,894
Based on past performance. This is not a recommendation.
Range: 53.56 USD - 79.96 USD (comparables only)
The price implies growth of 10.09% per year; the company grows at 11.14%.
Gross margin 62.2%, net margin 28.4%, ROIC 19.7%, ROE 42.6%.
Net margin
28.44%
Exceptional
Sector 8.30%|S&P 13.40%
Gross margin
62.16%
Exceptional
Return on equity (ROE)
42.64%
Exceptional
Sector 16.60%|S&P 17.06%
Return on invested capital (ROIC)
19.71%
Exceptional
Free cash flow margin (FCF)
27.76%
Exceptional
Profit-to-cash conversion (FCF conversion)
0.98x
High
Margin stability
6.5 pts
Uneven
Revenue to net income
Growth
2.5/10Revenue up 7.0% over 1 year, 7.9% a year over 5, EPS 11.1% a year over 5.
Revenue (trailing 12 months)
51.4Md USD
Revenue growth (1y)
6.99%
Solid
Revenue growth (3y)
12.96%
Moderate
EPS growth (1y)
8.45%
Moderate
EPS CAGR (5y)
11.14%
Strong
EPS revisions (3 months)
1.18%
Revised up
Valuation
2.2/10P/E 28.9x, forward P/E 28.5x, EV/EBITDA 27.1x, PEG 2.60. The multiple sits in the 100th percentile of its own 5-year history.
P/E (TTM)
28.9x
Expensive
Sector 19.5x|S&P 23.6x
Forward P/E
28.5x
Expensive
EV / EBITDA
27.1x
Very expensive
Sector 11.0x|S&P 15.5x
PEG
2.60
Very expensive
Sector 0.83|S&P 0.91
Fair value (reverse DCF)
66.76 USD
Deeply overvalued
P/E vs its own 5-year history
among the 1% highest valuations
At its historical high
Market cap
422Md USD
Financial strength
4.2/10Cash covers 39.9% of the debt, net debt/EBITDA 1.9x.
Net debt / EBITDA
1.9x
Stretched
Gearing (net debt / equity)
63.30%
Tight
Cash
16.6Md USD
Cash / market cap
3.93%
Tight
Cash / total debt
39.87%
Solid
Interest coverage
10.0x
Very solid
Net debt
25.0Md USD
Equity
39.5Md USD
Closed daily candles, 2 years
Last close on November 10, 2026: 96.91 USD
- MM2093.93
- MM5090.24
- MM20082.98
- RSI 1467.8
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
+3.05%
200-day average slope, 3 months
+8.05%
50-day average slope, 1 month
+2.51%
Price structure
higher-low
Bullish RSI divergence
No
20-day volatility
1.32 % per day
Volatility change
+4.84%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | 3.44 (6) | 3.34 (24) | 50 449 (19) | 17 571 (15) | 14 727 (4) |
| 2027 | 3.54 (8) | 3.53 (24) | 48 893 (19) | 18 263 (15) | 15 102 (6) |
Amounts in millions of USD, EPS in USD per share. In brackets, the number of analysts. Consensus as of November 10, 2026.
Same sub-industry: 46 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 9633 | 7.4 | 7.5 | 65.2Md USD | 26.8x | 30.2 % | 22.5 % | 49.5 % | -0.6x | 3.2 % | -15.5 % | ||
| 2 | CCH | 6.6 | 6.3 | 20.5Md USD | 18.4x | 8.1 % | 9.2 % | 13.3 % | 0.7x | 4.2 % | 20.1 % | ||
| 3 | FEMSA UBD | 6.6 | 6.5 | 26.7Md USD | 22.2x | 3.7 % | 18.4 % | 7.4 % | 1.2x | 15.6 % | 26.0 % | ||
| 4 | AC * | 6.4 | 5.5 | 21.5Md USD | 18.7x | 8.2 % | 5.9 % | 12.1 % | 0.7x | 4.4 % | 29.0 % | ||
| 5 | MNST | 6.1 | 5.0 | 88.9Md USD | 41.3x | 22.7 % | 16.7 % | 24.7 % | -1.1x | 2.2 % | 29.3 % | ||
| 6 | PEP | 5.8 | 6.0 | 196Md USD | 18.1x | 11.1 % | 5.6 % | 17.0 % | 2.3x | 5.3 % | 0.5 % | ||
| 7 | CCEP | 5.7 | 5.9 | 51.6Md USD | 23.3x | 9.3 % | -6.0 % | 11.0 % | 2.7x | 4.8 % | 26.3 % | ||
| 8 | KDP | 5.2 | 3.9 | 52.1Md USD | 35.0x | 7.1 % | 70.6 % | 3.5 % | 3.9x | 4.2 % | 46.1 % | ||
| 9 | KO | 5.1 | 4.6 | 422Md USD | 28.9x | 28.4 % | 7.0 % | 19.7 % | 1.9x | 3.4 % | 37.2 % |
